Mark J. Enyedy
2017
In 2017, Mark J. Enyedy earned a total compensation of $2.7M as President and Chief Executive Officer at ImmunoGen.
Compensation breakdown
| Non-Equity Incentive Plan | $753,750 |
|---|---|
| Salary | $670,000 |
| Stock Awards | $1,235,000 |
| Other | $8,784 |
| Total | $2,667,534 |
Enyedy received $1.2M in stock awards, accounting for 46% of the total pay in 2017.
Enyedy also received $753.8K in non-equity incentive plan, $670K in salary and $8.8K in other compensation.
Rankings
In 2017, Mark J. Enyedy's compensation ranked 4,155th out of 14,666 executives tracked by ExecPay. In other words, Enyedy earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,155 out of 14,666 | 72nd |
Division Manufacturing | 1,452 out of 5,772 | 75th |
Major group Chemicals And Allied Products | 417 out of 2,075 | 80th |
Industry group Drugs | 319 out of 1,731 | 82nd |
Industry Pharmaceutical Preparations | 254 out of 1,333 | 81st |
Source: SEC filing on April 28, 2020.
Enyedy's colleagues
We found four more compensation records of executives who worked with Mark J. Enyedy at ImmunoGen in 2017.